Jyong Biotech Ltd (MENS)’s stock has witnessed a price hike of 9.83% from the previous close with its current price standing at $43.25. Its current price is -35.45% under its 52-week high of $67.00 and 619.62% more than its 52-week low of $6.01. Based on the past 30-day period, the stock price is -34.78% below the high and +16.53% above the low.
How does Jyong Biotech Ltd (MENS) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Jyong Biotech Ltd (NASDAQ: MENS) Ownership Details
I will give a breakdown of the key shareholders in Jyong Biotech Ltd (MENS). Recent figures show that the company’s insiders hold 62.21% of shares. A total of 3 institutional investors hold shares in the company, making 0.14% of its stock and 0.36% of its float.
Jul 31, 2025, it was reported that the Company’s largest institutional holder is Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holding total of 10.43 shares that make 0.01% of the company’s total number of shares and are currently priced at 0.47 million.
An overview of Jyong Biotech Ltd’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Jyong Biotech Ltd (MENS) traded 340,243 shares per day, with a moving average of $55.28 and price change of -13.42. With the moving average of $43.99 and a price change of +33.64, about 210,221 shares changed hands on average over the past 50 days.
